Atypical antipsychotics: are some more atypical than others?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (56)
Clozapine for the Treatment-Resistant Schizophrenic
1988 • 4,030 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989 • 1,313 citations
Deficit and nondeficit forms of schizophrenia: the concept
1988 • 1,307 citations
Risperidone in the treatment of schizophrenia
1994 • 1,205 citations
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial
1997 • 906 citations
A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients
1993 • 884 citations
Serotonin-dopamine interaction and its relevance to schizophrenia
1996 • 822 citations
The schedule for the deficit syndrome: An instrument for research in schizophrenia
1989 • 806 citations
Olanzapine versus Placebo and Haloperidol
1996 • 788 citations
Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders
1997 • 722 citations
Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia
1999 • 706 citations
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
1988 • 554 citations
Childhood-Onset Schizophrenia
1996 • 395 citations
Optimal Dose of Neuroleptic in Acute Schizophrenia
1991 • 384 citations
Clinical and Biologic Response to Clozapine in Patients With Schizophrenia
1992 • 356 citations
Mechanisms of action of atypical antipsychotic drugs: a critical analysis
1996 • 315 citations
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
1992 • 302 citations
Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol
1997 • 287 citations
Tolerability and therapeutic effect of clozapine
1985 • 277 citations
Positive and Negative Symptom Response to Clozapine in Schizophrenic Patients With and Without the Deficit Syndrome
1998 • 258 citations
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study
1996 • 257 citations
Dimensions of Outcome with Clozapine
1992 • 256 citations
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
1997 • 253 citations
Olanzapine Compared With Chlorpromazine in Treatment-Resistant Schizophrenia
1998 • 239 citations
Risperidone: clinical safety and efficacy in schizophrenia.
1992 • 208 citations
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
1999 • 198 citations
An Exploratory Haloperidol-Controlled Dose-Finding Study of Ziprasidone in Hospitalized Patients With Schizophrenia or Schizoaffective Disorder
1998 • 188 citations
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
1993 • 177 citations
The history of clozapine
1989 • 170 citations
The New Atypical Antipsychotics
1994 • 168 citations
Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
1996 • 139 citations
Antipsychotic drugs: is more worse? a meta-analysis of the published randomized control trials
1994 • 136 citations
Randomized, Double-Blind, Controlled Trial of Risperidone Versus Clozapine in Patients With Chronic Schizophrenia
1995 • 122 citations
Olanzapine Versus Placebo and Haloperidol: Quality of Life and Efficacy Results of the North American Double-Blind Trial
1998 • 120 citations
Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic Patients
1996 • 120 citations
Clozapine's effect on negative symptoms in treatment-refractory schizophrenics
1994 • 112 citations
New antipsychotics: the present status
1995 • 102 citations
A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
1988 • 101 citations
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial
1995 • 99 citations
A new framework for investigating antipsychotic action in humans: lessons from PET imaging
1998 • 80 citations
Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study
1996 • 74 citations
Clozapine versus typical antipsychotics a retro- and prospective study of extrapyramidal side effects
1996 • 71 citations
Plasma Haloperidol Levels and Clinical Effects in Schizophrenia and Schizoaffective Disorder
1995 • 55 citations
Motor and mental side effects of clozapine.
1994 • 55 citations
Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone
1996 • 54 citations
Clozapine efficacy in schizophrenic nonresponders.
1988 • 44 citations
The new antipsychotics, and their potential for early intervention in schizophrenia
1997 • 42 citations
Treatment-resistant schizophrenia: clinical experience with new antipsychotics
1996 • 40 citations
Efficacy of Risperidone in Reducing Positive and Negative Symptoms in Medication-Refractory Schizophrenia
1996 • 40 citations
What Makes an Antipsychotic ‘Atypical’?
1997 • 37 citations
The negative component in schizophrenia
1995 • 29 citations
A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine
1995 • 25 citations
The Atypical Antipsychotic Sertindole
1997 • 15 citations
New findings on tardive dyskinesia in a community sample
1993 • 12 citations
Medical Complications and Selectivity of Therapeutic Response to Atypical Antipsychotic Drugs
1998 • 12 citations
LOW FREQUENCY OF TARDIVE DYSKINESIA IN ELDERLY PATIENTS WITH DEMENTIA EXPOSED TO RISPERIDONE FOR UP TO ONE YEAR
1999 • 9 citations